Global Liver Failure Therapeutics Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Liver Failure Therapeutics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Liver Failure Therapeutics Market Size Growth Rate by Product
  • 1.4.2 Ornithine Phenylacetate
  • 1.4.3 MTL-CEBPA
  • 1.4.4 F-573
  • 1.4.5 BL-1220
  • 1.4.6 PP-100
  • 1.4.7 Others
• 1.5 Market by End User
  • 1.5.1 Global Liver Failure Therapeutics Market Size Growth Rate by End User
  • 1.5.2 Clinic
  • 1.5.3 Hospital
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Liver Failure Therapeutics Market Size
  • 2.1.1 Global Liver Failure Therapeutics Revenue 2014-2025
  • 2.1.2 Global Liver Failure Therapeutics Sales 2014-2025
• 2.2 Liver Failure Therapeutics Growth Rate by Regions
  • 2.2.1 Global Liver Failure Therapeutics Sales by Regions
  • 2.2.2 Global Liver Failure Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Liver Failure Therapeutics Sales by Manufacturers
  • 3.1.1 Liver Failure Therapeutics Sales by Manufacturers
  • 3.1.2 Liver Failure Therapeutics Sales Market Share by Manufacturers
  • 3.1.3 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.2 Liver Failure Therapeutics Revenue by Manufacturers
  • 3.2.1 Liver Failure Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Liver Failure Therapeutics Revenue Share by Manufacturers (2014-2019)
• 3.3 Liver Failure Therapeutics Price by Manufacturers
• 3.4 Liver Failure Therapeutics Manufacturing Base Distribution, Product Types
  • 3.4.1 Liver Failure Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Liver Failure Therapeutics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Liver Failure Therapeutics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Liver Failure Therapeutics Sales by Product
• 4.2 Global Liver Failure Therapeutics Revenue by Product
• 4.3 Liver Failure Therapeutics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Liver Failure Therapeutics Breakdown Data by End User

6 North America

• 6.1 North America Liver Failure Therapeutics by Countries
  • 6.1.1 North America Liver Failure Therapeutics Sales by Countries
  • 6.1.2 North America Liver Failure Therapeutics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Liver Failure Therapeutics by Product
• 6.3 North America Liver Failure Therapeutics by End User

7 Europe

• 7.1 Europe Liver Failure Therapeutics by Countries
  • 7.1.1 Europe Liver Failure Therapeutics Sales by Countries
  • 7.1.2 Europe Liver Failure Therapeutics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Liver Failure Therapeutics by Product
• 7.3 Europe Liver Failure Therapeutics by End User

8 Asia Pacific

• 8.1 Asia Pacific Liver Failure Therapeutics by Countries
  • 8.1.1 Asia Pacific Liver Failure Therapeutics Sales by Countries
  • 8.1.2 Asia Pacific Liver Failure Therapeutics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Liver Failure Therapeutics by Product
• 8.3 Asia Pacific Liver Failure Therapeutics by End User

9 Central & South America

• 9.1 Central & South America Liver Failure Therapeutics by Countries
  • 9.1.1 Central & South America Liver Failure Therapeutics Sales by Countries
  • 9.1.2 Central & South America Liver Failure Therapeutics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Liver Failure Therapeutics by Product
• 9.3 Central & South America Liver Failure Therapeutics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Liver Failure Therapeutics by Countries
  • 10.1.1 Middle East and Africa Liver Failure Therapeutics Sales by Countries
  • 10.1.2 Middle East and Africa Liver Failure Therapeutics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Liver Failure Therapeutics by Product
• 10.3 Middle East and Africa Liver Failure Therapeutics by End User

11 Company Profiles

• 11.1 Alfact Innovation
  • 11.1.1 Alfact Innovation Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Alfact Innovation Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Alfact Innovation Liver Failure Therapeutics Products Offered
  • 11.1.5 Alfact Innovation Recent Development
• 11.2 BioLineRx Ltd
  • 11.2.1 BioLineRx Ltd Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 BioLineRx Ltd Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 BioLineRx Ltd Liver Failure Therapeutics Products Offered
  • 11.2.5 BioLineRx Ltd Recent Development
• 11.3 Cell2B Advanced Therapeutics SA
  • 11.3.1 Cell2B Advanced Therapeutics SA Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Products Offered
  • 11.3.5 Cell2B Advanced Therapeutics SA Recent Development
• 11.4 Conatus Pharmaceuticals Inc
  • 11.4.1 Conatus Pharmaceuticals Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Products Offered
  • 11.4.5 Conatus Pharmaceuticals Inc Recent Development
• 11.5 Immune Pharmaceuticals Inc
  • 11.5.1 Immune Pharmaceuticals Inc Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Products Offered
  • 11.5.5 Immune Pharmaceuticals Inc Recent Development
• 11.6 Mina Therapeutics Ltd
  • 11.6.1 Mina Therapeutics Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Products Offered
  • 11.6.5 Mina Therapeutics Ltd Recent Development
• 11.7 Mylan NV
  • 11.7.1 Mylan NV Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Mylan NV Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Mylan NV Liver Failure Therapeutics Products Offered
  • 11.7.5 Mylan NV Recent Development
• 11.8 Ocera Therapeutics Inc
  • 11.8.1 Ocera Therapeutics Inc Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Products Offered
  • 11.8.5 Ocera Therapeutics Inc Recent Development
• 11.9 PledPharma AB
  • 11.9.1 PledPharma AB Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 PledPharma AB Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 PledPharma AB Liver Failure Therapeutics Products Offered
  • 11.9.5 PledPharma AB Recent Development
• 11.10 Promethera Biosciences SA
  • 11.10.1 Promethera Biosciences SA Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Promethera Biosciences SA Liver Failure Therapeutics Products Offered
  • 11.10.5 Promethera Biosciences SA Recent Development
• 11.11 Silence Therapeutics Plc
• 11.12 Unicyte AG
• 11.13 Ventria Bioscience
• 11.14 Vital Therapies Inc

12 Future Forecast

• 12.1 Liver Failure Therapeutics Market Forecast by Regions
  • 12.1.1 Global Liver Failure Therapeutics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Liver Failure Therapeutics Revenue Forecast by Regions 2019-2025
• 12.2 Liver Failure Therapeutics Market Forecast by Product
  • 12.2.1 Global Liver Failure Therapeutics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Liver Failure Therapeutics Revenue Forecast by Product 2019-2025
• 12.3 Liver Failure Therapeutics Market Forecast by End User
• 12.4 North America Liver Failure Therapeutics Forecast
• 12.5 Europe Liver Failure Therapeutics Forecast
• 12.6 Asia Pacific Liver Failure Therapeutics Forecast
• 12.7 Central & South America Liver Failure Therapeutics Forecast
• 12.8 Middle East and Africa Liver Failure Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Liver Failure Therapeutics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details